PERBANDINGAN ANTARA PEMBERIAN REMDESIVIR DAN FAVIPIRAVIR TERHADAP LAMA RAWAT INAP PASIEN COVID-19DI RSUD R SYAMSUDIN SH SUKABUMI
Coronavirus disease 2019 (COVID-19) is a global public health problem which is estimated to have a severe disease progression and requires hospitalization. Pharmacological therapy, remdesivir and favipiravir are antiviral drugs that are recommended in the guidelines for the management of COVID-19 in...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
2023-01-09.
|
| Subjects: | |
| Online Access: | Link Metadata |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Coronavirus disease 2019 (COVID-19) is a global public health problem which is estimated to have a severe disease progression and requires hospitalization. Pharmacological therapy, remdesivir and favipiravir are antiviral drugs that are recommended in the guidelines for the management of COVID-19 in Indonesia. Pharmacological therapy aims to improve the clinical inpatients whose success can be measured by the duration of hospitalization. The purpose of this study was to find out the comparison between the administration of remdesivir and favipiravir on the length of stay of COVID-19 patients. This study used a cross-sectional design with a sample of 42 medical records of confirmed COVID-19 patients who fit the criteria and were selected using a purposive sampling technique. Data were analyzed using the T independent test. The results showed that there was a significant difference between the administration of remdesivir and favipiravir on the length of stay of COVID-19 patients (p <0.05). The average length of stay of COVID-19 patients who received favipiravir was shorter, which was 7.33 ± 1.983 (mean ± SD) compared to patients who received remdesivir, 9.29 ± 1.927 (mean ± SD). Based on the result, favipiravir is more effective than remdesivir in reducing the length of stay of COVID-19 patients, so favipiravir therapy can be chosen for patients who fit the criteria of this study to reduce the length of stay of COVID-19 patients. |
|---|---|
| Item Description: | http://repository.upnvj.ac.id/22900/1/ABSTRAK.pdf http://repository.upnvj.ac.id/22900/13/AWAL.pdf http://repository.upnvj.ac.id/22900/3/BAB%201.pdf http://repository.upnvj.ac.id/22900/4/BAB%202.pdf http://repository.upnvj.ac.id/22900/5/BAB%203.pdf http://repository.upnvj.ac.id/22900/16/BAB%204.pdf http://repository.upnvj.ac.id/22900/14/BAB%205.pdf http://repository.upnvj.ac.id/22900/15/DAFTAR%20PUSTAKA.pdf http://repository.upnvj.ac.id/22900/9/DAFTAR%20RIWAYAT%20HIDUP.pdf http://repository.upnvj.ac.id/22900/10/LAMPIRAN.pdf http://repository.upnvj.ac.id/22900/11/HASIL%20PLAGIARISME.pdf http://repository.upnvj.ac.id/22900/12/ARTIKEL%20KI.pdf |